Citi upgrades Novo Nordisk (NYSE: NVO) from Hold to Buy.

Citi analyst says, "We make significant cuts to our ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE